BUSINESSDAILY MAIL US
Brewers see big profits in small beers as GLP-1 drugs radically change US drinking habits
Brewers are experiencing increased profits due to rising demand for small beers as GLP-1 drugs significantly alter US drinking habits. The shift in consumer behavior is attributed to the impact of these medications on appetite and metabolism.
Related Signal
Adjacent reporting
- Young Czechs drink less beer but risk other addictions
- Weight loss drugs GLP-1s are shifting fashion and food trends
- Active ingredient in Ozempic shows early promise for treating alcohol use disorder
- Americans are drinking less, forcing changes among iconic bourbon businesses
- David Protein CEO says ‘diet trends are over’ because of GLP-1s: ‘What’s next is really hard to predict’